Cellectis is a clinical-stage biotechnology enterprise anchored primarily in Europe, with its global corporate headquarters situated in Paris, France. The primary corporate offices and primary laboratory research facilities are located within the heart of the capital's scientific and technological hub, directing core discovery operations. Additionally, to support its clinical development programs, regulatory interactions, and collaborative trials in North America, the company maintains a strategic operating presence and secondary facilities in New York City, United States, facilitating efficient cross-border scientific collaboration and clinical trial execution.